Rigel Pharmaceuticals
RIGL
#6160
Rank
NZ$1.53 B
Marketcap
NZ$84.46
Share price
3.25%
Change (1 day)
112.92%
Change (1 year)

Rigel Pharmaceuticals (RIGL) - Total assets

Total assets on the balance sheet as of September 2025 : NZ$0.41 Billion

According to Rigel Pharmaceuticals's latest financial reports the company's total assets are NZ$0.41 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Rigel Pharmaceuticals - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31NZ$0.29 B56.85%
2023-12-31NZ$0.18 B-12.36%
2022-12-31NZ$0.21 B-13.67%
2021-12-31NZ$0.24 B60.14%
2020-12-31NZ$0.15 B-30.18%
2019-12-31NZ$0.21 B5.66%
2018-12-31NZ$0.20 B23.65%
2017-12-31NZ$0.16 B48.69%
2016-12-31NZ$0.11 B-41.4%
2015-12-31NZ$0.19 B-2.15%
2014-12-31NZ$0.19 B-28.49%
2013-12-31NZ$0.27 B-27.01%
2012-12-31NZ$0.37 B14.41%
2011-12-31NZ$0.32 B36.13%
2010-12-31NZ$0.24 B24.88%
2009-12-31NZ$0.19 B-21.83%
2008-12-31NZ$0.24 B63.99%
2007-12-31NZ$0.15 B-5.96%
2006-12-31NZ$0.16 B-25.6%
2005-12-31NZ$0.21 B95.58%
2004-12-31NZ$0.11 B29.33%
2003-12-31NZ$85.41 M0.81%
2002-12-31NZ$84.72 M-24.25%
2001-12-31NZ$0.11 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
ChemoCentryx
CCXI
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
NZ$0.15 B-63.45%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$197.59 B 47,091.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
Amgen
AMGN
NZ$155.61 B 37,066.34%๐Ÿ‡บ๐Ÿ‡ธ USA